Global Neuroblastoma Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neuroblastoma Treatment market size was valued at US$ 434.3 million in 2023. With growing demand in downstream market, the Neuroblastoma Treatment is forecast to a readjusted size of US$ 557.5 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global Neuroblastoma Treatment market. Neuroblastoma Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuroblastoma Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuroblastoma Treatment market.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
Key Features:
The report on Neuroblastoma Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuroblastoma Treatment market. It may include historical data, market segmentation by Type (e.g., Combination Chemotherapy, Monoclonal Antibody Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuroblastoma Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuroblastoma Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuroblastoma Treatment industry. This include advancements in Neuroblastoma Treatment technology, Neuroblastoma Treatment new entrants, Neuroblastoma Treatment new investment, and other innovations that are shaping the future of Neuroblastoma Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuroblastoma Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Neuroblastoma Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuroblastoma Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuroblastoma Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuroblastoma Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuroblastoma Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuroblastoma Treatment market.
Market Segmentation:
Neuroblastoma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neuroblastoma Treatment market size was valued at US$ 434.3 million in 2023. With growing demand in downstream market, the Neuroblastoma Treatment is forecast to a readjusted size of US$ 557.5 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global Neuroblastoma Treatment market. Neuroblastoma Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuroblastoma Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuroblastoma Treatment market.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
Key Features:
The report on Neuroblastoma Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuroblastoma Treatment market. It may include historical data, market segmentation by Type (e.g., Combination Chemotherapy, Monoclonal Antibody Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuroblastoma Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuroblastoma Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuroblastoma Treatment industry. This include advancements in Neuroblastoma Treatment technology, Neuroblastoma Treatment new entrants, Neuroblastoma Treatment new investment, and other innovations that are shaping the future of Neuroblastoma Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuroblastoma Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Neuroblastoma Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuroblastoma Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuroblastoma Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuroblastoma Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuroblastoma Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuroblastoma Treatment market.
Market Segmentation:
Neuroblastoma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Combination Chemotherapy
- Monoclonal Antibody Therapy
- Vaccine Therapy
- Chimeric Antigen Receptor T-Cell Immunotherapy
- Oncolytic Virus Therapy
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seattle Children’s
- CureSearch
- Texas Children’s
- NANT
- Sino Biopharmaceutical
- Jiangsu Hengrui Medicine Co.,Ltd.
- Fosun Pharmaceutical
- Novartis
- Juno Therapeutics
- Kite Pharma
- Adaptimmune
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuroblastoma Treatment Market Size 2019-2030
2.1.2 Neuroblastoma Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuroblastoma Treatment Segment by Type
2.2.1 Combination Chemotherapy
2.2.2 Monoclonal Antibody Therapy
2.2.3 Vaccine Therapy
2.2.4 Chimeric Antigen Receptor T-Cell Immunotherapy
2.2.5 Oncolytic Virus Therapy
2.3 Neuroblastoma Treatment Market Size by Type
2.3.1 Neuroblastoma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
2.4 Neuroblastoma Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Neuroblastoma Treatment Market Size by Application
2.5.1 Neuroblastoma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
3 NEUROBLASTOMA TREATMENT MARKET SIZE BY PLAYER
3.1 Neuroblastoma Treatment Market Size Market Share by Players
3.1.1 Global Neuroblastoma Treatment Revenue by Players (2019-2024)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neuroblastoma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROBLASTOMA TREATMENT BY REGIONS
4.1 Neuroblastoma Treatment Market Size by Regions (2019-2024)
4.2 Americas Neuroblastoma Treatment Market Size Growth (2019-2024)
4.3 APAC Neuroblastoma Treatment Market Size Growth (2019-2024)
4.4 Europe Neuroblastoma Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuroblastoma Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuroblastoma Treatment Market Size by Country (2019-2024)
5.2 Americas Neuroblastoma Treatment Market Size by Type (2019-2024)
5.3 Americas Neuroblastoma Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuroblastoma Treatment Market Size by Region (2019-2024)
6.2 APAC Neuroblastoma Treatment Market Size by Type (2019-2024)
6.3 APAC Neuroblastoma Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuroblastoma Treatment by Country (2019-2024)
7.2 Europe Neuroblastoma Treatment Market Size by Type (2019-2024)
7.3 Europe Neuroblastoma Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuroblastoma Treatment by Region (2019-2024)
8.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROBLASTOMA TREATMENT MARKET FORECAST
10.1 Global Neuroblastoma Treatment Forecast by Regions (2025-2030)
10.1.1 Global Neuroblastoma Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Neuroblastoma Treatment Forecast
10.1.3 APAC Neuroblastoma Treatment Forecast
10.1.4 Europe Neuroblastoma Treatment Forecast
10.1.5 Middle East & Africa Neuroblastoma Treatment Forecast
10.2 Americas Neuroblastoma Treatment Forecast by Country (2025-2030)
10.2.1 United States Neuroblastoma Treatment Market Forecast
10.2.2 Canada Neuroblastoma Treatment Market Forecast
10.2.3 Mexico Neuroblastoma Treatment Market Forecast
10.2.4 Brazil Neuroblastoma Treatment Market Forecast
10.3 APAC Neuroblastoma Treatment Forecast by Region (2025-2030)
10.3.1 China Neuroblastoma Treatment Market Forecast
10.3.2 Japan Neuroblastoma Treatment Market Forecast
10.3.3 Korea Neuroblastoma Treatment Market Forecast
10.3.4 Southeast Asia Neuroblastoma Treatment Market Forecast
10.3.5 India Neuroblastoma Treatment Market Forecast
10.3.6 Australia Neuroblastoma Treatment Market Forecast
10.4 Europe Neuroblastoma Treatment Forecast by Country (2025-2030)
10.4.1 Germany Neuroblastoma Treatment Market Forecast
10.4.2 France Neuroblastoma Treatment Market Forecast
10.4.3 UK Neuroblastoma Treatment Market Forecast
10.4.4 Italy Neuroblastoma Treatment Market Forecast
10.4.5 Russia Neuroblastoma Treatment Market Forecast
10.5 Middle East & Africa Neuroblastoma Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Neuroblastoma Treatment Market Forecast
10.5.2 South Africa Neuroblastoma Treatment Market Forecast
10.5.3 Israel Neuroblastoma Treatment Market Forecast
10.5.4 Turkey Neuroblastoma Treatment Market Forecast
10.5.5 GCC Countries Neuroblastoma Treatment Market Forecast
10.6 Global Neuroblastoma Treatment Forecast by Type (2025-2030)
10.7 Global Neuroblastoma Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Information
11.1.2 Seattle Children’s Neuroblastoma Treatment Product Offered
11.1.3 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Seattle Children’s Main Business Overview
11.1.5 Seattle Children’s Latest Developments
11.2 CureSearch
11.2.1 CureSearch Company Information
11.2.2 CureSearch Neuroblastoma Treatment Product Offered
11.2.3 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CureSearch Main Business Overview
11.2.5 CureSearch Latest Developments
11.3 Texas Children’s
11.3.1 Texas Children’s Company Information
11.3.2 Texas Children’s Neuroblastoma Treatment Product Offered
11.3.3 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Texas Children’s Main Business Overview
11.3.5 Texas Children’s Latest Developments
11.4 NANT
11.4.1 NANT Company Information
11.4.2 NANT Neuroblastoma Treatment Product Offered
11.4.3 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 NANT Main Business Overview
11.4.5 NANT Latest Developments
11.5 Sino Biopharmaceutical
11.5.1 Sino Biopharmaceutical Company Information
11.5.2 Sino Biopharmaceutical Neuroblastoma Treatment Product Offered
11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sino Biopharmaceutical Main Business Overview
11.5.5 Sino Biopharmaceutical Latest Developments
11.6 Jiangsu Hengrui Medicine Co.,Ltd.
11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Information
11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered
11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Main Business Overview
11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments
11.7 Fosun Pharmaceutical
11.7.1 Fosun Pharmaceutical Company Information
11.7.2 Fosun Pharmaceutical Neuroblastoma Treatment Product Offered
11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fosun Pharmaceutical Main Business Overview
11.7.5 Fosun Pharmaceutical Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Neuroblastoma Treatment Product Offered
11.8.3 Novartis Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Juno Therapeutics
11.9.1 Juno Therapeutics Company Information
11.9.2 Juno Therapeutics Neuroblastoma Treatment Product Offered
11.9.3 Juno Therapeutics Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Juno Therapeutics Main Business Overview
11.9.5 Juno Therapeutics Latest Developments
11.10 Kite Pharma
11.10.1 Kite Pharma Company Information
11.10.2 Kite Pharma Neuroblastoma Treatment Product Offered
11.10.3 Kite Pharma Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Kite Pharma Main Business Overview
11.10.5 Kite Pharma Latest Developments
11.11 Adaptimmune
11.11.1 Adaptimmune Company Information
11.11.2 Adaptimmune Neuroblastoma Treatment Product Offered
11.11.3 Adaptimmune Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Adaptimmune Main Business Overview
11.11.5 Adaptimmune Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuroblastoma Treatment Market Size 2019-2030
2.1.2 Neuroblastoma Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuroblastoma Treatment Segment by Type
2.2.1 Combination Chemotherapy
2.2.2 Monoclonal Antibody Therapy
2.2.3 Vaccine Therapy
2.2.4 Chimeric Antigen Receptor T-Cell Immunotherapy
2.2.5 Oncolytic Virus Therapy
2.3 Neuroblastoma Treatment Market Size by Type
2.3.1 Neuroblastoma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
2.4 Neuroblastoma Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Neuroblastoma Treatment Market Size by Application
2.5.1 Neuroblastoma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
3 NEUROBLASTOMA TREATMENT MARKET SIZE BY PLAYER
3.1 Neuroblastoma Treatment Market Size Market Share by Players
3.1.1 Global Neuroblastoma Treatment Revenue by Players (2019-2024)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neuroblastoma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROBLASTOMA TREATMENT BY REGIONS
4.1 Neuroblastoma Treatment Market Size by Regions (2019-2024)
4.2 Americas Neuroblastoma Treatment Market Size Growth (2019-2024)
4.3 APAC Neuroblastoma Treatment Market Size Growth (2019-2024)
4.4 Europe Neuroblastoma Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuroblastoma Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuroblastoma Treatment Market Size by Country (2019-2024)
5.2 Americas Neuroblastoma Treatment Market Size by Type (2019-2024)
5.3 Americas Neuroblastoma Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuroblastoma Treatment Market Size by Region (2019-2024)
6.2 APAC Neuroblastoma Treatment Market Size by Type (2019-2024)
6.3 APAC Neuroblastoma Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuroblastoma Treatment by Country (2019-2024)
7.2 Europe Neuroblastoma Treatment Market Size by Type (2019-2024)
7.3 Europe Neuroblastoma Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuroblastoma Treatment by Region (2019-2024)
8.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROBLASTOMA TREATMENT MARKET FORECAST
10.1 Global Neuroblastoma Treatment Forecast by Regions (2025-2030)
10.1.1 Global Neuroblastoma Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Neuroblastoma Treatment Forecast
10.1.3 APAC Neuroblastoma Treatment Forecast
10.1.4 Europe Neuroblastoma Treatment Forecast
10.1.5 Middle East & Africa Neuroblastoma Treatment Forecast
10.2 Americas Neuroblastoma Treatment Forecast by Country (2025-2030)
10.2.1 United States Neuroblastoma Treatment Market Forecast
10.2.2 Canada Neuroblastoma Treatment Market Forecast
10.2.3 Mexico Neuroblastoma Treatment Market Forecast
10.2.4 Brazil Neuroblastoma Treatment Market Forecast
10.3 APAC Neuroblastoma Treatment Forecast by Region (2025-2030)
10.3.1 China Neuroblastoma Treatment Market Forecast
10.3.2 Japan Neuroblastoma Treatment Market Forecast
10.3.3 Korea Neuroblastoma Treatment Market Forecast
10.3.4 Southeast Asia Neuroblastoma Treatment Market Forecast
10.3.5 India Neuroblastoma Treatment Market Forecast
10.3.6 Australia Neuroblastoma Treatment Market Forecast
10.4 Europe Neuroblastoma Treatment Forecast by Country (2025-2030)
10.4.1 Germany Neuroblastoma Treatment Market Forecast
10.4.2 France Neuroblastoma Treatment Market Forecast
10.4.3 UK Neuroblastoma Treatment Market Forecast
10.4.4 Italy Neuroblastoma Treatment Market Forecast
10.4.5 Russia Neuroblastoma Treatment Market Forecast
10.5 Middle East & Africa Neuroblastoma Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Neuroblastoma Treatment Market Forecast
10.5.2 South Africa Neuroblastoma Treatment Market Forecast
10.5.3 Israel Neuroblastoma Treatment Market Forecast
10.5.4 Turkey Neuroblastoma Treatment Market Forecast
10.5.5 GCC Countries Neuroblastoma Treatment Market Forecast
10.6 Global Neuroblastoma Treatment Forecast by Type (2025-2030)
10.7 Global Neuroblastoma Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Information
11.1.2 Seattle Children’s Neuroblastoma Treatment Product Offered
11.1.3 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Seattle Children’s Main Business Overview
11.1.5 Seattle Children’s Latest Developments
11.2 CureSearch
11.2.1 CureSearch Company Information
11.2.2 CureSearch Neuroblastoma Treatment Product Offered
11.2.3 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CureSearch Main Business Overview
11.2.5 CureSearch Latest Developments
11.3 Texas Children’s
11.3.1 Texas Children’s Company Information
11.3.2 Texas Children’s Neuroblastoma Treatment Product Offered
11.3.3 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Texas Children’s Main Business Overview
11.3.5 Texas Children’s Latest Developments
11.4 NANT
11.4.1 NANT Company Information
11.4.2 NANT Neuroblastoma Treatment Product Offered
11.4.3 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 NANT Main Business Overview
11.4.5 NANT Latest Developments
11.5 Sino Biopharmaceutical
11.5.1 Sino Biopharmaceutical Company Information
11.5.2 Sino Biopharmaceutical Neuroblastoma Treatment Product Offered
11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sino Biopharmaceutical Main Business Overview
11.5.5 Sino Biopharmaceutical Latest Developments
11.6 Jiangsu Hengrui Medicine Co.,Ltd.
11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Information
11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered
11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Main Business Overview
11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments
11.7 Fosun Pharmaceutical
11.7.1 Fosun Pharmaceutical Company Information
11.7.2 Fosun Pharmaceutical Neuroblastoma Treatment Product Offered
11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fosun Pharmaceutical Main Business Overview
11.7.5 Fosun Pharmaceutical Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Neuroblastoma Treatment Product Offered
11.8.3 Novartis Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Juno Therapeutics
11.9.1 Juno Therapeutics Company Information
11.9.2 Juno Therapeutics Neuroblastoma Treatment Product Offered
11.9.3 Juno Therapeutics Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Juno Therapeutics Main Business Overview
11.9.5 Juno Therapeutics Latest Developments
11.10 Kite Pharma
11.10.1 Kite Pharma Company Information
11.10.2 Kite Pharma Neuroblastoma Treatment Product Offered
11.10.3 Kite Pharma Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Kite Pharma Main Business Overview
11.10.5 Kite Pharma Latest Developments
11.11 Adaptimmune
11.11.1 Adaptimmune Company Information
11.11.2 Adaptimmune Neuroblastoma Treatment Product Offered
11.11.3 Adaptimmune Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Adaptimmune Main Business Overview
11.11.5 Adaptimmune Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuroblastoma Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Combination Chemotherapy
Table 3. Major Players of Monoclonal Antibody Therapy
Table 4. Major Players of Vaccine Therapy
Table 5. Major Players of Chimeric Antigen Receptor T-Cell Immunotherapy
Table 6. Major Players of Oncolytic Virus Therapy
Table 7. Neuroblastoma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 10. Neuroblastoma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 13. Global Neuroblastoma Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Neuroblastoma Treatment Revenue Market Share by Player (2019-2024)
Table 15. Neuroblastoma Treatment Key Players Head office and Products Offered
Table 16. Neuroblastoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Neuroblastoma Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Neuroblastoma Treatment Market Size Market Share by Regions (2019-2024)
Table 21. Global Neuroblastoma Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Neuroblastoma Treatment Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Neuroblastoma Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Neuroblastoma Treatment Market Size Market Share by Country (2019-2024)
Table 25. Americas Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 27. Americas Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 29. APAC Neuroblastoma Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Table 31. APAC Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 33. APAC Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 35. Europe Neuroblastoma Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Neuroblastoma Treatment Market Size Market Share by Country (2019-2024)
Table 37. Europe Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 39. Europe Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Neuroblastoma Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Neuroblastoma Treatment
Table 48. Key Market Challenges & Risks of Neuroblastoma Treatment
Table 49. Key Industry Trends of Neuroblastoma Treatment
Table 50. Global Neuroblastoma Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Neuroblastoma Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Neuroblastoma Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Seattle Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 55. Seattle Children’s Neuroblastoma Treatment Product Offered
Table 56. Seattle Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Seattle Children’s Main Business
Table 58. Seattle Children’s Latest Developments
Table 59. CureSearch Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 60. CureSearch Neuroblastoma Treatment Product Offered
Table 61. CureSearch Main Business
Table 62. CureSearch Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. CureSearch Latest Developments
Table 64. Texas Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 65. Texas Children’s Neuroblastoma Treatment Product Offered
Table 66. Texas Children’s Main Business
Table 67. Texas Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Texas Children’s Latest Developments
Table 69. NANT Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 70. NANT Neuroblastoma Treatment Product Offered
Table 71. NANT Main Business
Table 72. NANT Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. NANT Latest Developments
Table 74. Sino Biopharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 75. Sino Biopharmaceutical Neuroblastoma Treatment Product Offered
Table 76. Sino Biopharmaceutical Main Business
Table 77. Sino Biopharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sino Biopharmaceutical Latest Developments
Table 79. Jiangsu Hengrui Medicine Co.,Ltd. Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 80. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered
Table 81. Jiangsu Hengrui Medicine Co.,Ltd. Main Business
Table 82. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments
Table 84. Fosun Pharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 85. Fosun Pharmaceutical Neuroblastoma Treatment Product Offered
Table 86. Fosun Pharmaceutical Main Business
Table 87. Fosun Pharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Fosun Pharmaceutical Latest Developments
Table 89. Novartis Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 90. Novartis Neuroblastoma Treatment Product Offered
Table 91. Novartis Main Business
Table 92. Novartis Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Novartis Latest Developments
Table 94. Juno Therapeutics Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 95. Juno Therapeutics Neuroblastoma Treatment Product Offered
Table 96. Juno Therapeutics Main Business
Table 97. Juno Therapeutics Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Juno Therapeutics Latest Developments
Table 99. Kite Pharma Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 100. Kite Pharma Neuroblastoma Treatment Product Offered
Table 101. Kite Pharma Main Business
Table 102. Kite Pharma Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Kite Pharma Latest Developments
Table 104. Adaptimmune Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 105. Adaptimmune Neuroblastoma Treatment Product Offered
Table 106. Adaptimmune Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Adaptimmune Main Business
Table 108. Adaptimmune Latest Developments
Table 1. Neuroblastoma Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Combination Chemotherapy
Table 3. Major Players of Monoclonal Antibody Therapy
Table 4. Major Players of Vaccine Therapy
Table 5. Major Players of Chimeric Antigen Receptor T-Cell Immunotherapy
Table 6. Major Players of Oncolytic Virus Therapy
Table 7. Neuroblastoma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 10. Neuroblastoma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 13. Global Neuroblastoma Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Neuroblastoma Treatment Revenue Market Share by Player (2019-2024)
Table 15. Neuroblastoma Treatment Key Players Head office and Products Offered
Table 16. Neuroblastoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Neuroblastoma Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Neuroblastoma Treatment Market Size Market Share by Regions (2019-2024)
Table 21. Global Neuroblastoma Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Neuroblastoma Treatment Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Neuroblastoma Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Neuroblastoma Treatment Market Size Market Share by Country (2019-2024)
Table 25. Americas Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 27. Americas Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 29. APAC Neuroblastoma Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Table 31. APAC Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 33. APAC Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 35. Europe Neuroblastoma Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Neuroblastoma Treatment Market Size Market Share by Country (2019-2024)
Table 37. Europe Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 39. Europe Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Neuroblastoma Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Neuroblastoma Treatment
Table 48. Key Market Challenges & Risks of Neuroblastoma Treatment
Table 49. Key Industry Trends of Neuroblastoma Treatment
Table 50. Global Neuroblastoma Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Neuroblastoma Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Neuroblastoma Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Seattle Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 55. Seattle Children’s Neuroblastoma Treatment Product Offered
Table 56. Seattle Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Seattle Children’s Main Business
Table 58. Seattle Children’s Latest Developments
Table 59. CureSearch Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 60. CureSearch Neuroblastoma Treatment Product Offered
Table 61. CureSearch Main Business
Table 62. CureSearch Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. CureSearch Latest Developments
Table 64. Texas Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 65. Texas Children’s Neuroblastoma Treatment Product Offered
Table 66. Texas Children’s Main Business
Table 67. Texas Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Texas Children’s Latest Developments
Table 69. NANT Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 70. NANT Neuroblastoma Treatment Product Offered
Table 71. NANT Main Business
Table 72. NANT Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. NANT Latest Developments
Table 74. Sino Biopharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 75. Sino Biopharmaceutical Neuroblastoma Treatment Product Offered
Table 76. Sino Biopharmaceutical Main Business
Table 77. Sino Biopharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sino Biopharmaceutical Latest Developments
Table 79. Jiangsu Hengrui Medicine Co.,Ltd. Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 80. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered
Table 81. Jiangsu Hengrui Medicine Co.,Ltd. Main Business
Table 82. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments
Table 84. Fosun Pharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 85. Fosun Pharmaceutical Neuroblastoma Treatment Product Offered
Table 86. Fosun Pharmaceutical Main Business
Table 87. Fosun Pharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Fosun Pharmaceutical Latest Developments
Table 89. Novartis Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 90. Novartis Neuroblastoma Treatment Product Offered
Table 91. Novartis Main Business
Table 92. Novartis Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Novartis Latest Developments
Table 94. Juno Therapeutics Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 95. Juno Therapeutics Neuroblastoma Treatment Product Offered
Table 96. Juno Therapeutics Main Business
Table 97. Juno Therapeutics Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Juno Therapeutics Latest Developments
Table 99. Kite Pharma Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 100. Kite Pharma Neuroblastoma Treatment Product Offered
Table 101. Kite Pharma Main Business
Table 102. Kite Pharma Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Kite Pharma Latest Developments
Table 104. Adaptimmune Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors
Table 105. Adaptimmune Neuroblastoma Treatment Product Offered
Table 106. Adaptimmune Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Adaptimmune Main Business
Table 108. Adaptimmune Latest Developments
LIST OF FIGURES
Figure 1. Neuroblastoma Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuroblastoma Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuroblastoma Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuroblastoma Treatment Sales Market Share by Country/Region (2023)
Figure 8. Neuroblastoma Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuroblastoma Treatment Market Size Market Share by Type in 2023
Figure 10. Neuroblastoma Treatment in Hospitals
Figure 11. Global Neuroblastoma Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Neuroblastoma Treatment in Clinics
Figure 13. Global Neuroblastoma Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Neuroblastoma Treatment in Others
Figure 15. Global Neuroblastoma Treatment Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Neuroblastoma Treatment Market Size Market Share by Application in 2023
Figure 17. Global Neuroblastoma Treatment Revenue Market Share by Player in 2023
Figure 18. Global Neuroblastoma Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Neuroblastoma Treatment Value Market Share by Country in 2023
Figure 24. United States Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Neuroblastoma Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Neuroblastoma Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Neuroblastoma Treatment Market Size Market Share by Application in 2023
Figure 31. China Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Neuroblastoma Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Neuroblastoma Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Neuroblastoma Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neuroblastoma Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuroblastoma Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuroblastoma Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuroblastoma Treatment Sales Market Share by Country/Region (2023)
Figure 8. Neuroblastoma Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuroblastoma Treatment Market Size Market Share by Type in 2023
Figure 10. Neuroblastoma Treatment in Hospitals
Figure 11. Global Neuroblastoma Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Neuroblastoma Treatment in Clinics
Figure 13. Global Neuroblastoma Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Neuroblastoma Treatment in Others
Figure 15. Global Neuroblastoma Treatment Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Neuroblastoma Treatment Market Size Market Share by Application in 2023
Figure 17. Global Neuroblastoma Treatment Revenue Market Share by Player in 2023
Figure 18. Global Neuroblastoma Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Neuroblastoma Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Neuroblastoma Treatment Value Market Share by Country in 2023
Figure 24. United States Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Neuroblastoma Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Neuroblastoma Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Neuroblastoma Treatment Market Size Market Share by Application in 2023
Figure 31. China Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Neuroblastoma Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Neuroblastoma Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Neuroblastoma Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Neuroblastoma Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Neuroblastoma Treatment Market Size Market Share Forecast by Application (2025-2030)
